Filing Details

Accession Number:
0001209191-21-065058
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-17 16:05:23
Reporting Period:
2021-11-16
Accepted Time:
2021-11-17 16:05:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1671818 Oncorus Inc. ONCR Pharmaceutical Preparations (2834) 473779757
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835251 Stephen Harbin C/O Oncorus, Inc.
50 Hampshire Street, Suite 401
Cambridge MA 02139
Coo And Chief Of Staff No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-16 15,000 $5.80 15,000 No 4 P Direct
Common Stock Acquisiton 2021-11-16 15,000 $5.78 15,000 No 4 P Indirect By Stephen W. Harbin Irrevocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Stephen W. Harbin Irrevocable Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.745 to $5.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.73 to $5.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  3. The Reporting Person serves as trustee of the Stephen Harbin Irrevocable Trust and has sole voting and investment control over the shares held by the trust.